A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Pfizer Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 1,332,406 shares of PFE stock, worth $37.3 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,332,406
Previous 1,440,906 7.53%
Holding current value
$37.3 Million
Previous $41.5 Million 10.87%
% of portfolio
0.18%
Previous 0.24%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $2.81 Million - $3.23 Million
-108,500 Reduced 7.53%
1,332,406 $37 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $6.18 Million - $8.03 Million
-236,614 Reduced 14.1%
1,440,906 $41.5 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $1.54 Million - $1.8 Million
47,998 Added 2.95%
1,677,520 $55.6 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $68.6 Million - $79.4 Million
-1,899,381 Reduced 53.82%
1,629,522 $59.8 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $25.5 Million - $33.2 Million
-647,925 Reduced 15.51%
3,528,903 $144 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $14.8 Million - $19.3 Million
-354,790 Reduced 7.83%
4,176,828 $214 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $32.7 Million - $39.9 Million
-746,473 Reduced 14.14%
4,531,618 $198 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $5.44 Million - $6.45 Million
-116,840 Reduced 2.17%
5,278,091 $277 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $31.2 Million - $38.7 Million
682,717 Added 14.49%
5,394,931 $280 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $45.9 Million - $68 Million
1,110,707 Added 30.84%
4,712,214 $275 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $34.2 Million - $43.9 Million
870,956 Added 31.9%
3,601,507 $155 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $1.03 Million - $1.17 Million
-28,811 Reduced 1.04%
2,730,551 $107 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $17.7 Million - $19.9 Million
-527,211 Reduced 16.04%
2,759,362 $100 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $15.4 Million - $19.6 Million
461,143 Added 16.32%
3,286,573 $121 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $3.77 Million - $4.42 Million
118,652 Added 4.38%
2,825,430 $104 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $133,913 - $162,456
4,446 Added 0.16%
2,706,778 $88.5 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $8.69 Million - $12.4 Million
321,613 Added 13.51%
2,702,332 $88.2 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $26.7 Million - $30.3 Million
810,325 Added 51.6%
2,380,719 $93.3 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $3.97 Million - $5.15 Million
-122,264 Reduced 7.22%
1,570,394 $56.4 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $30.5 Million - $34.2 Million
-824,533 Reduced 32.76%
1,692,658 $73.3 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $207 Million - $228 Million
-5,522,523 Reduced 68.69%
2,517,191 $107 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $17.5 Million - $19.9 Million
-454,049 Reduced 5.35%
8,039,714 $351 Million
Q3 2018

Nov 05, 2018

BUY
$34.47 - $41.81 $58 Million - $70.3 Million
1,681,524 Added 24.68%
8,493,763 $374 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $21.5 Million - $23 Million
653,352 Added 10.61%
6,812,239 $247 Million
Q1 2018

Apr 30, 2018

BUY
$31.91 - $37.02 $131 Million - $152 Million
4,099,742 Added 199.1%
6,158,887 $219 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $15.8 Million - $16.8 Million
475,207 Added 30.0%
2,059,145 $74.6 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $2.75 Million - $3.03 Million
88,653 Added 5.93%
1,583,938 $56.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,495,285
1,495,285 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.